Selective estrogen-receptor modulators and aromatase inhibitors: promising new medical therapies for endometriosis?

Author： Simsa Peter   Mihalyi Attila   Kyama Cleophas M   Mwenda Jason M   Fülöp Vilmos   D’Hooghe Thomas M  

Publisher： Future Medicine

ISSN： 1745-5057

Source： Women's Health, Vol.3, Iss.5, 2007-09, pp. : 617-628

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Selective estrogen receptor modulators

By Petersen Nicole   Briggs Amber  

Clinical Review in Bone and Mineral Metabolism, Vol. 3, Iss. 1, 2005-03 ,pp. : 19-30

Humana Press, Inc

Access to resources Recommend Favorite

Bazedoxifene: a selective estrogen-receptor modulator

By Mitwally Mohamed FM  

Women's Health, Vol. 4, Iss. 4, 2008-07 ,pp. : 319-326

Future Medicine

Access to resources Recommend Favorite

Raloxifene: a selective estrogen-receptor modulator for postmenopausal osteoporosis – a clinical update on efficacy and safety

By Deal Chad L   Draper Michael W  

Women's Health, Vol. 2, Iss. 2, 2006-03 ,pp. : 199-210

Future Medicine

Access to resources Recommend Favorite

Expression of Estrogen Receptor Beta and Phosphorylation of Estrogen Receptor Alpha Serine 167 Correlate with Progression-Free Survival in Patients with Metastatic Breast Cancer Treated with Aromatase Inhibitors

By  

Oncology, Vol. 79, Iss. 1-2, 2010-11 ,pp. : 55-61

Karger

Access to resources Recommend Favorite

Association of aromatase and estrogen receptor gene polymorphisms with hip fractures

By Valero C.   Pérez-Castrillón J.   Zarrabeitia M.   Hernández J.   Alonso M.   Pino-Montes J.   Olmos J.   González-Macías J.   Riancho J.  

Osteoporosis International, Vol. 19, Iss. 6, 2008-06 ,pp. : 787-792

Springer Publishing Company

Access to resources Recommend Favorite